|
Market Cap (5-Jun) $55,535,856 (1,270th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 227,504 |
Shortsold (18-Aug) 146,107 (0.01%) (520th) |
|
52w High $0.045 |
52w Low $0.040 |
P/E - |
EPS 0.03 |
DNA released this announcement to the ASX on 22 November 2022, 8:30. The announcement is not marked as price sensitive, and is 13 page(s) in length and 0.96MB in size.
You can view all announcements from DNA and see how they appear on a price chart on the announcements page.
At the date of this announcement, DNA was 0.012% short sold according to ASIC data. It was ranked the 520th most shorted stock on the ASX. It remains ranked 520th as of the latest reported data (18 August 2025).
| Other Recent Announcements from DNA | |
|---|---|
| Quarterly Activities Report | 28 April 2023, 16:17 |
| Appendix 4C Cash Flow Report | 28 April 2023, 16:15 |
| 1H FY23 Results Summary | 1 March 2023, 8:45 |
| FY22 AGM Presentation | 22 November 2022, 8:30 |
| Appendix 4C Cash Flow Report (Amended) | 31 October 2022, 9:21 |
| Quarterly Activities Report | 28 October 2022, 14:05 |
| Appendix 4C Cash Flow Report | 28 October 2022, 14:03 |
You must be logged in to post a reply.
Donaco International 